Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, announced today that it has received clearance ...

The FDA will decide later this month whether to approve a novel drug for acute pain that could offer a nonaddictive ...

New use of gabapentin (Neurontin) was not associated with greater risk of falls in older adults with neuropathy or ...

Our experts tested the most popular pillows for every type of sleeper to find the best pillows for neck pain. Shop this list ...

After thousands of complaints about complications, the FDA has issued an open letter to veterinarians to be alert to serious ...

In a world where health supplements are increasingly prevalent, finding a product that genuinely supports your well-being can ...

A trial with XG005 met it's primary and secondary endpoints, demonstrating a statistically significant reduction in post-surgery pain compared to placebo.

NEW YORK, NY / ACCESSWIRE / January 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...

Safety concerns Keros observed in a Phase 2 trial triggered a stock selloff for what had been one of the sector’s most successful initial public offerings of the last four years, according to ...

Low-level laser therapy is a non-invasive treatment for TMJ symptoms that uses light to stimulate cellular activity, and it's ...

Treatment with XG005 resulted in statistically significant and clinically meaningful reduction in post-surgical pain ...